Results 201 to 210 of about 115,141 (275)

Online survey: An exploration of the perceived impact of physiotherapy in children with Ataxia Telangiectasia (AT)

, 2020
Lisa Bunn, Tracey Parkin, Myrto Karagianni-Xanthaki   +2 more
openalex   +1 more source

PARP inhibitor BMN673 triggers PARylation-mediated ATF4-GDF15 pathway to drive autophagy and ferroptosis in ataxia telangiectasia mutated gene-deficient colorectal cancer cells. [PDF]

Mol Biomed
Xiang J, Xu J, Fan H, Chen Q, Lu Y, Wan X, Jiang Y, Zhang X, Zhang C, Liu Q, Ding D, Lei Y.   +11 more
europepmc   +1 more source

Targeting Ataxia Telangiectasia-Mutated and Rad3-Related for Anaplastic Thyroid Cancer. [PDF]

Cancers (Basel)
Lin SF, Hsueh C, Chen WY, Chou TC, Wong RJ.   +4 more
europepmc   +1 more source

Population Pharmacokinetic Modeling and Pediatric Exposure of Dexamethasone Sodium Phosphate Encapsulated in Erythrocytes (eDSP) Administered Monthly for Treatment of Neurological Symptoms of Patients With Ataxia Telangiectasia. [PDF]

CPT Pharmacometrics Syst Pharmacol
Ozdin D, Kheibarshekan L, Mambrini G, Mambrini G, Tremblay PO.   +4 more
europepmc   +1 more source

ATM Expression and Activation in Ataxia Telangiectasia Patients with and without Class Switch Recombination Defects. [PDF]

J Clin Immunol
Salami F, Shad TM, Fathi N, Mojtahedi H, Esmaeili M, Shahkarami S, Afrakoti LGMP, Amirifar P, Delavari S, Nosrati H, Razavi A, Ranjouri MR, Yousefpour M, Esfahani ZH, Azizi G, Ashrafi M, Rezaei N, Yazdani R, Abolhassani H.   +18 more
europepmc   +1 more source

Phase 2a/b randomised placebo-controlled dose-escalation trial of triheptanoin for ataxia-telangiectasia: treating mitochondrial dysfunction with anaplerosis. [PDF]

EBioMedicine
Lynch M, Manoy S, Sly PD, Wainwright CE, Wolvetang E, Feenstra JE, Dowling J, Ware RS, Patel MS, Hermith-Ramirez D, Vogel A, Preece K, Zappala T, Dai S, Webber A, Yeo A, Subramanian G, Rao G, Ma CS, Jose S, Gatei M, Xin B, Sandona N, Lewindon P, Sinclair KG, Nayler S, Lavin MF, Coman DJ.   +27 more
europepmc   +1 more source

Role of Ataxia-Telangiectasia Mutated Kinase in Cardiac Autophagy and Glucose Metabolism Under Ischemic Conditions

, 2018
Patsy R. Thrasher
openalex   +1 more source

Disruption of ataxia telangiectasia-mutated kinase enhances radiation therapy efficacy in spatially directed diffuse midline glioma models. [PDF]

J Clin Invest
Mangoli A, Valentine V, Maingi SM, Wu SR, Liu HQ, Aksu M, Jain V, Foreman BE, Regal JA, Weidenhammer LB, Stewart CE, Guerra Garcia ME, Hocke E, Abramson K, Michaeli TF, Williams NT, Luo L, Romero M, Deland K, Gadd S, Uchida E, Attardi L, Abe K, Hashizume R, Ashley DM, Becher OJ, Kirsch DG, Gregory SG, Reitman ZJ.   +28 more
europepmc   +1 more source

Safety and Tolerability of Berzosertib, an Ataxia-Telangiectasia-Related Inhibitor, and Veliparib, an Oral Poly (ADP-ribose) Polymerase Inhibitor, in Combination With Cisplatin in Patients With Refractory Solid Tumors. [PDF]

JCO Precis Oncol
O'Sullivan Coyne G, Do KT, Kummar S, Piha-Paul S, Rubinstein L, Kinders R, Parchment RE, Wilsker D, Ferry-Galow K, Miller B, Takebe N, Juwara L, Ong MJ, Bruns A, Hogu M, Naqash AR, Mittra A, Voth AR, Doroshow JH, Chen AP.   +19 more
europepmc   +1 more source

Long-term safety of dexamethasone sodium phosphate encapsulated in autologous erythrocytes in pediatric patients with ataxia telangiectasia. [PDF]

Front Neurol
Koenig MK, Leuzzi V, Gouider R, Yiu EM, Pietrucha B, Stray-Pedersen A, Perlman SL, Wu S, Burgers T, Borgohain R, Kandadai RM, Meyts I, Bucciol G, Udwadia-Hegde A, Yadav R, Roberts D, Dane A, Roden M, Thye D, Horn B, Lederman HM, Whitehouse WP.   +21 more
europepmc   +1 more source